1. Home
  2. TBPH vs JBGS Comparison

TBPH vs JBGS Comparison

Compare TBPH & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.34

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Logo JBG SMITH Properties

JBGS

JBG SMITH Properties

HOLD

Current Price

$14.43

Market Cap

906.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
JBGS
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
824.9M
906.3M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
TBPH
JBGS
Price
$16.34
$14.43
Analyst Decision
Buy
Sell
Analyst Count
6
1
Target Price
$18.40
$15.00
AVG Volume (30 Days)
282.6K
563.4K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
4.69%
EPS Growth
279.13
N/A
EPS
N/A
N/A
Revenue
$15,386,000.00
$498,598,000.00
Revenue This Year
$8.46
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.10
$13.99
52 Week High
$21.03
$24.30

Technical Indicators

Market Signals
Indicator
TBPH
JBGS
Relative Strength Index (RSI) 46.74 44.49
Support Level $16.14 $14.17
Resistance Level $17.21 $16.07
Average True Range (ATR) 0.38 0.49
MACD -0.07 -0.08
Stochastic Oscillator 29.31 22.02

Price Performance

Historical Comparison
TBPH
JBGS

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.

Share on Social Networks: